Jump to content

Search the Community

Showing results for tags 'clinical trial'.

The search index is currently processing. Current results may not be complete.
  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


    • Announcements, meetings and other resources
    • Primary hormone therapy
    • Secondary hormone therapy
    • Castrate Resistant Prostate Cancer
    • Metastatic
    • Very high risk
    • New agents
    • Every little bit helps
    • Radiation, diagnostic imaging, bones and other prostate cancer topics
    • Articles on other sites
    • My story
    • Any suggestions?
    • The lounge

Find results in...

Find results that contain...

Date Created

  • Start


Last Updated

  • Start


Filter by number of...

Found 2 results

  1. Jim Marshall (not a doctor) said ... In this video Prostate Cancer Research Institute Executive Director Mark Scholz talks about a clinical trial for men who are metastatic and have rising psa on hormone therapy. The trial is testing whether adding the PARP inhibitor Lynparza (olaparib) to the super-hormone Zytiga (abiraterone) increases its effectiveness. You can find out about the clinical trial at: https://clinicaltrials.gov/ct2/show/study/NCT03732820?show_locs=Y#locn Details there include: inclusion details (things you need to get into the trial); exclusion details (what will keep you out of the trial); and locations. Australian locations include: Box Hill, Australia, 3128 Darlinghurst, Australia, 2010 Greenslopes, Australia, 4120 Herston, Australia, 4029 Kingswood, Australia, 2747 Kurralta Park, Australia, 5037 St Albans, Australia, 3021 Waratah, Australia, 2298 As always, ask your doctor if you think this might be for you. ... end Jim
  2. The trial is titled "Using Theranostics Early to Eradicate Prostate Cancer and Developing Novel Strategies for PSMA Negative Disease". These clinical trials are headed by Prof. Michael Hofman and A/Prof. Arun Azad of Peter Mac. Recruiting is expected start early next year.Details of these trials will follow later this year. In essence, Lutetium will be given earlier in the piece, Lutetium will in special circumstances be given prior to robotic surgery, Research will commence into CAR T cell treatment for prostate cancer which is not PSMA avid and cannot currently be treated using Lutetium. A dedicated team of specialist Doctors,Scientists and Clinical Researchers at Peter Mac have just successfully applied to the Movember/ Cancer Australia Prostate Cancer Research Alliance for funding of these new Lutetium trials. (see details by clicking this link to the Peter Mac site) http://tinyurl.com/y36xuwqg This is a world-class proposal from a world-class multi-institutional Australian team. Movember and Cancer Australia will jointly provide $4M in funding to the Alliance. In addition generous financial support for these trials totalling $1.4M will also be provided by Peter Mac Foundation, University of Melbourne, Victoria Cancer Agency, Monash University, Epworth/E.J Whitten Foundation, Peter Mac Research Division. This funding will be used solely for prostate cancer research The grant interview team for this project consisted of Prof. Michael Hofman, A/Prof. Arun Azad, A/Prof. Declan Murphy and yours truly as a consumer representative. Hopefully these trials will provide a quantum leap forward for prostate cancer treatment.
  • Create New...